Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Femasys Inc. - Common Stock (NQ:FEMY)

2.600 +0.040 (+1.56%)
Streaming Delayed Price Updated: 11:00 AM EDT, Sep 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 18,617
Open 2.610
Bid (Size) 2.520 (1,000)
Ask (Size) 2.600 (500)
Prev. Close 2.560
Today's Range 2.540 - 2.736
52wk Range 2.022 - 22.20
Shares Outstanding 11,813,610
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Femasys Advances OB/GYN Expansion with Adoption of FemaSeed® Fertility Portfolio by Minnesota Women’s Care
From Femasys Inc.
Via GlobeNewswire
News headline image
Femasys Partners with CapexMD to Expand Patient Access to FemaSeed® Fertility Portfolio
Collaboration provides dedicated patient financing for Femasys fertility solutions, helping reduce financial barriers to care across OB/GYN practices and fertility centers 
From Femasys Inc.
Via GlobeNewswire

Performance

YTD
-79.6%
-79.6%
1 Month
+20.4%
+20.4%
3 Month
-32.3%
-32.3%
6 Month
-77.6%
-77.6%
1 Year
-64.5%
-64.5%

More News

Read More
News headline image
Femasys Partners with UNC Health to Introduce Its FemaSeed® Fertility Portfolio Across Statewide OB/GYN Care Locations
From Femasys Inc.
Via GlobeNewswire
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
News headline image
Femasys Announces FDA Approval of Modular PMA Submission Approach for FemBloc®
From Femasys Inc.
Via GlobeNewswire
News headline image
Femasys Announces Financial Results for Quarter Ended June 30, 2026 and Provides Corporate Update
From Femasys Inc.
Via GlobeNewswire
News headline image
Femasys Strengthens and Extends Global Patent Protection for FemBloc® with First Issued Blended Polymer Patents
From Femasys Inc.
Via GlobeNewswire
News headline image
Femasys Secures $30 Million Private Placement, with Potential Proceeds of Up to $90 Million
From Femasys Inc.
Via GlobeNewswire
News headline image
Femasys Regains Compliance with Nasdaq Listing Requirements
From Femasys Inc.
Via GlobeNewswire
News headline image
Innoviva Stock Is Up Just 10% This Past Year. Here's Why a Fund Bought $2.5 Million More ↗
Via The Motley Fool
Topics Regulatory Compliance
Wondering what's happening in today's after-hours session? ↗
Via Chartmill
Get insights into the top gainers and losers of Friday's after-hours session. ↗
Via Chartmill
News headline image
Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG™ Catheter
From Femasys Inc.
Via GlobeNewswire
News headline image
Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update
From Femasys Inc.
Via GlobeNewswire
News headline image
Femasys Enables OB/GYNs to Deliver First-Line Fertility Treatment with Initial Commercial Use of FemaSeed® Complete
From Femasys Inc.
Via GlobeNewswire
News headline image
Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026
From Femasys Inc.
Via GlobeNewswire
News headline image
Femasys Drives International Growth with Israeli Market Entry for Fertility Portfolio
From Femasys Inc.
Via GlobeNewswire
News headline image
Femasys Appoints John Canning as Chief Operating Officer to Drive Operational Execution and Advance Commercial Growth
From Femasys Inc.
Via GlobeNewswire
News headline image
Femasys Announces Financial Results for Year Ended December 31, 2025 and Provides Corporate Update
From Femasys Inc.
Via GlobeNewswire
Traders are paying attention to the gapping stocks in Monday's session. ↗
Via Chartmill
News headline image
Femasys Appoints Dr. Kenneth D. Eichenbaum to Board of Directors
From Femasys Inc.
Via GlobeNewswire
News headline image
Femasys Advances FemBloc Toward U.S. Approval with Initiation of Pivotal Trial Enrollment
From Femasys Inc.
Via GlobeNewswire
News headline image
Femasys Announces FemBloc® Permanent Birth Control Has Achieved MDSAP Certification, Advancing Global Market Access
From Femasys Inc.
Via GlobeNewswire
News headline image
Femasys Receives AMA CPT Editorial Panel Approval for New Category III CPT Code for FemaSeed Intratubal Insemination
From Femasys Inc.
Via GlobeNewswire
News headline image
Femasys Expands European Commercial Footprint with Swiss Partner for FemBloc, FemaSeed, and Portfolio Products
From Femasys Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Femasys Inc. - Common Stock publicly traded?
Yes, Femasys Inc. - Common Stock is publicly traded.
What exchange does Femasys Inc. - Common Stock trade on?
Femasys Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Femasys Inc. - Common Stock?
The ticker symbol for Femasys Inc. - Common Stock is FEMY on the Nasdaq Stock Market
What is the current price of Femasys Inc. - Common Stock?
The current price of Femasys Inc. - Common Stock is 2.600
When was Femasys Inc. - Common Stock last traded?
The last trade of Femasys Inc. - Common Stock was at 09/16/26 11:00 AM ET
What is the market capitalization of Femasys Inc. - Common Stock?
The market capitalization of Femasys Inc. - Common Stock is 30.72M
How many shares of Femasys Inc. - Common Stock are outstanding?
Femasys Inc. - Common Stock has 31M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.